If you see a gross white sludge under your oil cap, it might be your car's way of dealing with built-up water and oil. Here's how to handle it.

Renasant Bio, an underdog in the race to develop kidney disease therapies, raises $54.5 million The company is focused on treatments for a condition known as ADPKD Adobe By Allison DeAngelis July ...

BP and Shell have signed new deals with Libya’s NOC to explore and assess oil and gas fields, signaling Big Oil’s broader return to the country after years of instability.

Mustang Bio shares are trading sharply higher Monday afternoon. The FDA granted Orphan Drug Designation to its cell therapy, MB-101.

Exxon Mobil, Occidental Petroleum OXY-1.06%decrease; red down pointing triangle and other oil giants are expected to receive billions of dollars of incentives to collect and bury carbon emissions ...

Vor Bio is licensing global rights to a fusion protein that inhibits two targets to potentially treat the neuromuscular disorder generalized myasthenia gravis. It’s a pivot for Vor, which last ...

Less than two months after Vor Bio telegraphed a strategic review, the former cell therapy biotech has made a surprise comeback with a potential $4 billion deal licensing a China-made autoimmune ...

Global crude prices jumped on Sunday but have since retreated. Here's what experts say about the outlook for oil and gas.

Infinity Bio, a biotechnology company pioneering technologies to map immune responses at scale, today announced the successful closing of an $8 million Serie ...

I’ve gathered data on how oil and stocks typically behave after a weekly spike in crude prices. Let’s see if these scenarios have historically produce high-probability trading opportunities.

At BIO Day 1, we're covering the Chinese NewCo model for biotech, investment in oncology facing financial and political headwinds, and more.